Oligopeptides that mimic segments of the amino acid sequence of hemoglobin S at potential contact sites can be used to inhibit aggregation. These oligopeptide inhibitors raise the minimum gelling concentration of deoxyhemoglobin
P 125634, do not alter the percent increase in the minimum gelling concentration. Leu-and Met-enkephalin increase the minimum gelling concentration just as #1-6 does, but (Pro)6 is not very effective. Thus, the use of complementary oligopeptides as inhibitors is extended to include certain "flexible" peptides, which can adapt themselves to interfere with the molecular contacts and thereby gelation of deoxyhemoglobin S. The primary sequence of hemoglobin (Hb) S at the NH2 terminus of the two /3 chains is 1 5 10 Val-His-Leu-Thr-Pro-Val-Glu-Lys-Ser-Ala ... Out of 574 amino acid residues of the normal adult Hb A molecule, only two glutamic acid residues in the 6 position of the /3 chains are replaced by two valine residues in Hb S. The /36 region lies on the surface of the Hb molecule. Residues /1-3 are nonhelical; residues /34-19 form helix A. The specificity of the gelation of deoxyHb S suggests some minor conformational difference between Hb S and Hb A in solution. Intuitively we might suspect that the /31-6 region is a possible contact site between neighboring molecules. One of us further suggested that the first turn of helix A in Hb S might be unwound to adapt the first six residues for aggregation between neighboring Hb molecules (1). (Proline is a helix breaker, but /35 Pro is tolerated in Hb A at the beginning of a helix that does not have hydrogen bonds.) This possible change in local conformation could occur before or during gelation of deoxyHb S in solution. However, x-ray diffraction of Hb S crystals may not be able to detect this small difference, which might be present only in the aggregate.
Our working hypothesis (1) is that oligopeptides mimicking portions of the amino acid sequence at the contact sites of the protein molecule might be used to inhibit aggregation. DeoxyHb S molecules aggregate to form nuclei (nucleation), which rapidly grow into a fiber-like gel (polymerization) (2 ... His-Leu-Asp-Asn-Leu-Lys-Gly-Thr. .. is a candidate for contact with ,/S1-6 of another molecule. The geometric arrangement is such that the deoxy-form (the T conformer according to some allosteric models) makes such a contact possible. Originally the contacts were thought to exist in the same strand rather than in the adjacent strand as the x-ray crystallographers have now proposed (4, 5) . For a molecule as large as Hb, the number of contact sites between neighboring molecules of both intra-and inter-strands must be large, but the mutation site (31-6 region) might be an important contact area for the formation of fibers. It is worth recalling that in arterial blood the Hb is 95-98% saturated with oxygen. The so-called deoxygenated state in the venous blood of a normal adult retains about 70% saturation of oxygen. Even though the binding affinity of oxygen by Hb S is lower than that by Hb A (6, 7), the deoxyHb S in vvo still has a considerable amount of bound oxygen. Thus, the fibrous structure of deoxyHb S that is completely devoid of oxygen, as postulated from x-ray diffraction studies (4, 5) , may differ from that of Hb S inside the sickle cell. L. Peller (personal communication) points out that the aggregates of deoxyHb S in vivo resemble a copolymer of Hb S 
molecules having various
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. dipeptide, which was converted into an azide in ethylacetate at 40 before being coupled with other peptides because it contained a histidine residue); (iii) to convert the COOH-terminal amino acid into an amide; (iv) to prepare longer peptides by coupling shorter ones; and (v) to remove the protecting groups in boron tris(trifluoroacetate) (15) . The final products were passed through a Dowex-l chloride column.
Determination of Minimum Gelling Concentration. The MGC of deoxyHb S was followed visually in a test tube (16) . Deoxgenation was done by nitrogen flush over the solution and its completion was checked spectroscopically (12) . To avoid a thin film forming at the gas-liquid surface during deoxygenation, we used a small magnetic bar inside the tube and slowly moved it at intervals with another magnetic bar outside the tube. (The omission of this step would give a false high MGC.) For protein concentrations above MGC, Hb S usually gelled within 5-10 min after nitrogen flush at 37°. Near MGC, deoxyHb S gelled in about 20-25 min. If gelation did not occur after 1.5-2 hr, we considered the Hb S concentration below its MGC. Each experimental point was the average of three measurements; its MGC varied by about +0.5%. Since the MGC is slightly dependent on ionic strength, appropriate amounts of NaCl were added to the control experiments (Hb S alone) to compensate for the change in ionic strength due to the added oligopeptides. Fig. 1 . First, in all cases the oligopeptide additives increase the MGC of deoxyHb S, more so at higher molar ratios of the peptide to heme. The increase seems to gradually level off above peptide/heme _ 2. Second, /3A1-6 amide ( Fig. 1 right) is essentially as effective as OS1-6 amide (Fig. 1 left) To further test this point, we studied the effect of two enkephalins, Tyr-Gly-Gly-Phe-Met and Tyr-Gly-Gly-Phe-Leu, as additives; they are believed to inhibit the binding of morphine to the synaptic plasma membrane and therefore are of current interest in pharmacology. Their effects on AMGC/MGC are about the same as the effect of /31-6 hexapeptide amide (Fig.  2 right) . At present it is difficult to say where the binding sites for the two pentapeptides are.
RESULTS

Figs
The conformation of free oligopeptides is largely "random" in solution, but they may adopt a fixed conformation once attached to a protein. In fact this is necessary if they supplant a region of the j3-chain sequence of the Hb molecule. Hexa-Lproline amide is less flexible than any other hexapeptide studied; possibly (Pro)6 is less adaptable and thus less able to interfere at the contact area of the Hb aggregates (Fig. 2 right) .
Certain amino acids, such as L-homoserine, L-glutamine, and L-asparagine, have been reported to inhibit and reverse the sickling of erythrocytes in vitro (except for irreversible sickle cells) (19) (20) (21) . However, L-homoserine, for instance, has little or no effect on the increase in MGC (Fig. 2 right) The function of an antisickling agent is essentially to raise the MGC of deoxyHb S so high that the protein will not gel at physiological concentrations. In our experiments in vitro the Hb molecules are completely deoxygenated, unlike the so-called deoxyHb S inside the erythrocytes, which retains a considerable amount of bound oxygen. However, our MGC values in the presence of oligopeptides (Figs. 1 and 2 ) are much lower than the mean intracellular Hb concentration. (The pH used in our experiments was also lower than that inside the erythrocytes.) However, Minton (23, 24) found that the tendency of Hb S to aggregate only slightly decreased with increasing oxygen saturation until the fractional saturation of nonaggregated Hb S exceeded one-half.
However potent any antiaggregation agent for Hb S may be found to be, its transport across the cell membrane is a serious problem. New techniques must be developed to overcome this difficulty. One approach is to search for an oligopeptide permease like the carrier Ames et al. (25) have found for Eschericha coli. Another approach is to partially lyse the erythrocytes and subsequently reseal them (26, 27) . This allows the oligopeptides to enter the membrane before reclosure. The drawback is that not all the Hb molecules return to the interior of the cells. The same is true for compounds other than Hb. The extent to which erythrocytes are damaged during this cycle of opening and resealing is still unknown. Frequently we found that the reconstituted erythrocytes did not possess the biconcave shape (J. T. Yang, unpublished data). Perhaps the use of liposomes as potential carriers of oligopeptides is a promising approach. This is an area of expanding interest (28) (29) (30) with perhaps a potential applicability to the entry problem.
Addendum. After completing this work we were gratified to learn that Votano et al. (31) also used certain tri-and tetrapeptides as noncovalently bound inhibitors for the gelation of deoxyHb S.
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